Financials

  • Market Capitalization 265.4 M
  • Employee 59
  • Founded 2019
  • CEO N/A
  • Website www.sionnatx.com
  • Headquarter Delaware, United States
  • FIGI BBG016X2DC85
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-21.88
Price to sales ratio
4 110.11

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3419
ACIU
AC Immune SA - Common Stock
2.65 USD-2.21%-8.93%+15.22%+27.40%269.62 M USD
3420
PYXS
Pyxis Oncology, Inc. - Common Stock
3.23 USD-2.71%+6.95%+9.49%+152.34%269.41 M USD
3431
SRZN
Surrozen, Inc. - Common Stock
22.42 USD-6.62%-4.39%+16.47%+86.37%263.51 M USD
3433
WHWK
Whitehawk Therapeutics, Inc. - Common Stock
4.62 USD-5.13%-2.53%+25.54%+53.49%263.38 M USD

Frequently asked questions about Sionna Therapeutics, Inc. Common Stock

What is the Sionna Therapeutics, Inc. Common Stock stock price today?

The current price of Sionna Therapeutics, Inc. Common Stock (SION) is 5.87. Over the past 24 hours, the stock has changed by -3.14%. Follow the SION chart for real-time price dynamics.

What is the stock ticker of Sionna Therapeutics, Inc. Common Stock?

Sionna Therapeutics, Inc. Common Stock trades under the ticker SION. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Sionna Therapeutics, Inc. Common Stock stock going up?

SION has changed by +11.17% over the last week, -86.87% over the last month, and -85.08% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Sionna Therapeutics, Inc. Common Stock?

Sionna Therapeutics, Inc. Common Stock currently has a market capitalization of 265.4 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Sionna Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Sionna Therapeutics, Inc. Common Stock reported earnings of -0.66 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Sionna Therapeutics, Inc. Common Stock revenue for the last quarter?

Sionna Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Sionna Therapeutics, Inc. Common Stock net income for the last quarter?

Sionna Therapeutics, Inc. Common Stock reported net income of -29.89 M for the last quarter. The previous quarter showed -26.78 M, which means net income changed by -11.60%.

How many employees does Sionna Therapeutics, Inc. Common Stock have?

As of the latest available data, Sionna Therapeutics, Inc. Common Stock has 59 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Sionna Therapeutics, Inc. Common Stock stock?

You can buy Sionna Therapeutics, Inc. Common Stock (SION) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Sionna Therapeutics, Inc. Common Stock stock?

Investing in Sionna Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SION chart and related analysis on metatrader.com as part of your research.